Clinical Trial Update: The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2 [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial evaluated whether peptide-loaded dendritic cells could augment the therapeutic effect of interleukin-2 in patients with metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Peptide-loaded dendritic cell vaccine (dendritic cell vaccine)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: COMPLETED